Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.661, 2012-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Barriers to the uptake of new high-cost cancer drugs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 605, 2010-01 ,pp. :
Access to resources
Recommend
Impact of High‐Cost Drugs for Individual Patient Use
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 2, 2004-06 ,pp. :
Access to High‐Cost Drugs: Decision Makers' Perspectives
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 1, 2005-03 ,pp. :
Biopharmaceuticals a high-cost gamble
Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 11, 2006-01 ,pp. :
Safety-Related Regulatory Actions for Orphan Drugs in the US and EU: A Cohort Study
Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. :